SK Bioscience joins US-backed project to develop Bundibugyo Ebola vaccine
SK Bioscience will join global partners in a U.S. government-funded project to develop and produce a vaccine against the Bundibugyo virus, a strain of Ebola spreading in the Democratic Republic of the Congo, the Korean vaccine maker said Thursday. The project, carried out with the International AIDS Vaccine Initiative (IAVI), a global nonprofit biomedical research organization, and…
Read original article on Korea Times News →Related news
-
Husband who poured boiling water on Thai wife gets sentence reduction on appeal
Crime & Justice
Crime
South Korea
-
US official calls Korean firms' participation in nuclear expansion 'almost mandatory'
Science
Energy
United States
-
[PHOTOS] 4 years on: The enduring grief of Itaewon's bereaved families
Other
South Korea
-
NK leader may have discussed potential talks with US during China visit: spy agency
International
Diplomacy
North Korea
-
Seongdong District opens one-stop service counter for foreign residents
Politics
Local Government
South Korea
-
Yongsan opens English library for kids combining AI tech, interactive exhibits
Technology
AI
South Korea
-
Gachon University president hosts 120 international students at traditional hanok
-
Global coffee brands to converge in Seoul for int'l cafe show
Business
Retail
South Korea